Mirtazapine (adjunct) versus placebo for schizophrenia

Suzanne Stricklin, Luke A. Perry, Dhruvesh Ramson

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To systematically assess the effects of mirtazapine as adjunct treatment for people with schizophrenia.

Original languageEnglish
Article numberCD011943
Number of pages13
JournalCochrane Database of Systematic Reviews
Volume2015
Issue number11
DOIs
Publication statusPublished - 11 Nov 2015

Cite this